FDA Inspection
Northwind Pharmaceuticals LLCNorthwind Pharmaceuticals LLC – FDA Inspection, Sep 26, 2025
Record Details
This FDA Inspection record concerns Northwind Pharmaceuticals LLC, with an inspection on September 26, 2025, issued by the Detroit District Office, covering human drugs.
View Company Profile
ID · 8b79ec99-302f-400e-86ca-9d147afd5419
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1256379
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Northwind Pharmaceuticals LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 16, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 9, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 14, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 14, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Northwind Pharmaceuticals LLC
- FDA Inspection 1073148 - 2018-11-16
- FDA Inspection 1011451 - 2017-03-13
- FDA Inspection 952157 - 2015-12-09
- FDA Inspection 944649 - 2015-09-14
- FDA Inspection 900116 - 2014-10-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.